NO163452C - Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater. - Google Patents
Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater.Info
- Publication number
- NO163452C NO163452C NO861630A NO861630A NO163452C NO 163452 C NO163452 C NO 163452C NO 861630 A NO861630 A NO 861630A NO 861630 A NO861630 A NO 861630A NO 163452 C NO163452 C NO 163452C
- Authority
- NO
- Norway
- Prior art keywords
- sup
- group
- sub
- hydrogen atom
- atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9198885 | 1985-04-27 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO861630L NO861630L (no) | 1986-10-28 |
NO163452B NO163452B (no) | 1990-02-19 |
NO163452C true NO163452C (no) | 1990-05-30 |
Family
ID=14041841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO861630A NO163452C (no) | 1985-04-27 | 1986-04-25 | Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater. |
Country Status (17)
Country | Link |
---|---|
US (1) | US4771046A (de) |
EP (1) | EP0202048B1 (de) |
JP (1) | JPH0710868B2 (de) |
KR (1) | KR920010076B1 (de) |
AT (1) | ATE69053T1 (de) |
AU (1) | AU583113B2 (de) |
CA (1) | CA1305709C (de) |
DE (1) | DE3682225D1 (de) |
DK (1) | DK189686A (de) |
ES (1) | ES8800952A1 (de) |
FI (1) | FI81577C (de) |
HU (1) | HU194882B (de) |
IE (1) | IE58892B1 (de) |
NO (1) | NO163452C (de) |
NZ (1) | NZ215957A (de) |
PH (1) | PH22555A (de) |
ZA (1) | ZA863109B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0759581B2 (ja) * | 1986-09-05 | 1995-06-28 | 日本レダリ−株式会社 | (1r)−1−メチルカルバペネム−3−カルボン酸誘導体 |
JPS6425780A (en) * | 1987-04-28 | 1989-01-27 | Sankyo Co | 1-methylcarbapenem derivative |
IE910606A1 (en) * | 1990-02-23 | 1991-08-28 | Sankyo Co | Carbapenem derivatives having antibiotic activity, their¹preparation and their use |
US5712267A (en) * | 1991-06-04 | 1998-01-27 | Sankyo Company,. Limited | Carbapenem derivatives, their preparation and their use as antibiotics |
KR970706284A (ko) | 1994-09-16 | 1997-11-03 | 나가사까 겐지로 | 신규의 카르바페넴 유도체(novel carbapenem deriative) |
CA2199855A1 (en) * | 1994-09-16 | 1996-03-21 | Ryosuke Ushijima | Novel carbapenem derivative |
US5932048A (en) * | 1995-04-06 | 1999-08-03 | Komatsu Electronic Metals Co., Ltd. | Method of fabricating direct-bonded semiconductor wafers |
US20070234661A1 (en) * | 2005-01-28 | 2007-10-11 | Ed Vaes | Multi piece curved moldings |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0017992A1 (de) * | 1979-04-19 | 1980-10-29 | Merck & Co. Inc. | 2-Substituierte-6-substituierte-1-Carbadethiapen-2-em-3-carbonsäuren, Verfahren zu ihrer Herstellung, sie enthaltende antibiotische pharmazeutische Zusammensetzungen und Verfahren zur Herstellung von Zwischenprodukten |
PT73791B (en) * | 1980-10-17 | 1983-10-14 | Merck & Co Inc | Process for preparing 2-carbamimidoyl-6-substituted-1- -carbadethiapen-2-em-3-carboxylic acids |
EP0060612A1 (de) * | 1981-02-04 | 1982-09-22 | Beecham Group Plc | Verfahren zur Herstellung von Azabicyclo(3.2.0)-hept-2-en-Derivaten |
ES514240A0 (es) * | 1981-08-03 | 1984-04-16 | Merck & Co Inc | Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados. |
JPS60178888A (ja) * | 1984-02-22 | 1985-09-12 | Sankyo Co Ltd | ペネムまたはカルバペネム誘導体およびその製法 |
-
1986
- 1986-04-24 AU AU56710/86A patent/AU583113B2/en not_active Ceased
- 1986-04-24 NZ NZ215957A patent/NZ215957A/en unknown
- 1986-04-24 DK DK189686A patent/DK189686A/da not_active Application Discontinuation
- 1986-04-25 US US06/856,696 patent/US4771046A/en not_active Expired - Fee Related
- 1986-04-25 NO NO861630A patent/NO163452C/no unknown
- 1986-04-25 HU HU861736A patent/HU194882B/hu not_active IP Right Cessation
- 1986-04-25 ZA ZA863109A patent/ZA863109B/xx unknown
- 1986-04-25 FI FI861763A patent/FI81577C/fi not_active IP Right Cessation
- 1986-04-26 JP JP9726086A patent/JPH0710868B2/ja not_active Expired - Fee Related
- 1986-04-26 KR KR1019860003237A patent/KR920010076B1/ko not_active IP Right Cessation
- 1986-04-28 ES ES554474A patent/ES8800952A1/es not_active Expired
- 1986-04-28 AT AT86303193T patent/ATE69053T1/de not_active IP Right Cessation
- 1986-04-28 EP EP86303193A patent/EP0202048B1/de not_active Expired - Lifetime
- 1986-04-28 CA CA000507751A patent/CA1305709C/en not_active Expired - Fee Related
- 1986-04-28 IE IE110686A patent/IE58892B1/en not_active IP Right Cessation
- 1986-04-28 PH PH33710A patent/PH22555A/en unknown
- 1986-04-28 DE DE8686303193T patent/DE3682225D1/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA1305709C (en) | 1992-07-28 |
DK189686A (da) | 1986-10-28 |
JPS6230781A (ja) | 1987-02-09 |
NZ215957A (en) | 1988-04-29 |
AU583113B2 (en) | 1989-04-20 |
HU194882B (en) | 1988-03-28 |
EP0202048B1 (de) | 1991-10-30 |
NO861630L (no) | 1986-10-28 |
EP0202048A1 (de) | 1986-11-20 |
US4771046A (en) | 1988-09-13 |
KR920010076B1 (ko) | 1992-11-13 |
DK189686D0 (da) | 1986-04-24 |
PH22555A (en) | 1988-10-17 |
AU5671086A (en) | 1986-10-30 |
ES554474A0 (es) | 1987-12-01 |
FI861763A (fi) | 1986-10-28 |
JPH0710868B2 (ja) | 1995-02-08 |
FI81577C (fi) | 1990-11-12 |
IE58892B1 (en) | 1993-12-01 |
FI81577B (fi) | 1990-07-31 |
DE3682225D1 (de) | 1991-12-05 |
KR860008178A (ko) | 1986-11-12 |
ES8800952A1 (es) | 1987-12-01 |
NO163452B (no) | 1990-02-19 |
HUT40661A (en) | 1987-01-28 |
ZA863109B (en) | 1986-12-30 |
FI861763A0 (fi) | 1986-04-25 |
IE861106L (en) | 1986-10-27 |
ATE69053T1 (de) | 1991-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7906000L (sv) | Terapeutiskt aktiva, substituerade piperidiner och pyrrolidiner | |
ES513109A0 (es) | "procedimiento de preparacion de derivados de 1-fenil-1-hidroxi-etilamina". | |
DE68917023D1 (de) | 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen. | |
NO173867C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider | |
AU531586B2 (en) | Morpholine derivatives | |
NO166126C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
NO163452C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater. | |
HU9202294D0 (en) | Method for producing new medical preparatives containing diphenyl-imidazole derivatives and their active agents | |
IE790630L (en) | 2, 6-dialkoxybenzamido-pyrrolidines. | |
ES473441A1 (es) | Procedimiento para la preparacion de nuevos derivados de 5,-11-dihidro-6h-pirido (2,3-b)(1,4-benzodiazepin-6-ona). | |
IE791881L (en) | Chromanol derivatives | |
EP0123962A3 (en) | Novel benzimidazole derivative, process for the preparation thereof and pharmaceutical composition | |
TW280810B (de) | ||
GB1433103A (en) | Pharmacologically active pyrrolodiazepines | |
DK424888D0 (da) | Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater | |
DK0471856T3 (da) | 15-Deoxyprostaglandin-derivater | |
ATE6514T1 (de) | Clavulansaeure-derivate, ihre herstellung und pharmazeutische zubereitungen. | |
EP0272849A3 (en) | Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases |